MDT vs MRSN · P/E 21, rev $36.36B vs rev $40.5M
Medtronic PLC (MDT) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the MDT and MRSN stock pages for the full models.
Not investment advice.